1-Methyladenosine

CAS No. 15763-06-1

1-Methyladenosine( —— )

Catalog No. M22280 CAS No. 15763-06-1

1-Methyladenosine (M1A) belongs to the class of organic compounds known as purine nucleosides.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
25MG 31 In Stock
50MG 44 In Stock
100MG 63 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Methyladenosine
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Methyladenosine (M1A) belongs to the class of organic compounds known as purine nucleosides.
  • Description
    1-Methyladenosine (M1A) belongs to the class of organic compounds known as purine nucleosides.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Endogenous Metabolite
  • Recptor
    Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    15763-06-1
  • Formula Weight
    281.27
  • Molecular Formula
    C11H15N5O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:145 mg/mL (515.52 mM; Need ultrasonic)
  • SMILES
    CN(C=Nc1c2ncn1[C@@H]([C@@H]1O)O[C@H](CO)[C@H]1O)C2=N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hauenschild R, et al. The reverse transcription signature of N-1-methyladenosine in RNA-Seq is sequence dependent. Nucleic Acids Res. 2015 Nov 16;43(20):9950-64.
molnova catalog
related products
  • 2-Hydroxybutyric aci...

    2-Hydroxybutyric acid (α-Hydroxybutyric acid) is a product of protein metabolism and serves as a biomarker for type 2 diabetes and pre-eclampsia.

  • Indole-3-carboxylic ...

    Indole-3-carboxylic acid is a normal urinary indolic tryptophan metabolite .

  • Cholesteryl oleate

    Cholesteryl oleate is a cholesteryl ester. Cholesteryl oleate can be used to synthesize solid lipid nanoparticles which is a nanoparticle-based gene therapy approach.